全文获取类型
收费全文 | 735篇 |
免费 | 41篇 |
国内免费 | 39篇 |
专业分类
耳鼻咽喉 | 2篇 |
儿科学 | 19篇 |
妇产科学 | 5篇 |
基础医学 | 63篇 |
口腔科学 | 14篇 |
临床医学 | 87篇 |
内科学 | 306篇 |
皮肤病学 | 5篇 |
神经病学 | 17篇 |
特种医学 | 91篇 |
外科学 | 28篇 |
综合类 | 19篇 |
预防医学 | 54篇 |
眼科学 | 27篇 |
药学 | 45篇 |
中国医学 | 9篇 |
肿瘤学 | 24篇 |
出版年
2021年 | 6篇 |
2020年 | 5篇 |
2018年 | 8篇 |
2017年 | 5篇 |
2015年 | 15篇 |
2014年 | 14篇 |
2013年 | 26篇 |
2012年 | 23篇 |
2011年 | 19篇 |
2010年 | 26篇 |
2009年 | 23篇 |
2008年 | 27篇 |
2007年 | 51篇 |
2006年 | 34篇 |
2005年 | 35篇 |
2004年 | 25篇 |
2003年 | 27篇 |
2002年 | 12篇 |
2001年 | 21篇 |
2000年 | 12篇 |
1999年 | 10篇 |
1998年 | 26篇 |
1997年 | 20篇 |
1996年 | 17篇 |
1995年 | 12篇 |
1994年 | 18篇 |
1993年 | 15篇 |
1992年 | 13篇 |
1991年 | 17篇 |
1990年 | 19篇 |
1989年 | 19篇 |
1988年 | 20篇 |
1987年 | 11篇 |
1986年 | 17篇 |
1985年 | 12篇 |
1984年 | 7篇 |
1983年 | 14篇 |
1982年 | 7篇 |
1980年 | 9篇 |
1979年 | 5篇 |
1978年 | 6篇 |
1977年 | 5篇 |
1976年 | 8篇 |
1969年 | 4篇 |
1945年 | 4篇 |
1944年 | 4篇 |
1841年 | 7篇 |
1840年 | 13篇 |
1838年 | 8篇 |
1830年 | 5篇 |
排序方式: 共有815条查询结果,搜索用时 15 毫秒
41.
Jack X Yu Anieta M Sieuwerts Yi Zhang John WM Martens Marcel Smid Jan GM Klijn Yixin Wang John A Foekens 《BMC cancer》2007,7(1):182
Background
Published prognostic gene signatures in breast cancer have few genes in common. Here we provide a rationale for this observation by studying the prognostic power and the underlying biological pathways of different gene signatures. 相似文献42.
WM Bisset P Stapleford S Long A Chamberlain B Sokel PJ Milla 《Archives of disease in childhood》1992,67(1):109-114
In children with severe failure of intestinal function, intravenous nutrition is at present the only treatment able to maintain adequate nutrition for prolonged periods of time. Over the last five years we have discharged 10 patients home on parenteral nutrition for a total of 25 patient years and here the outcome of these children is presented. Of the 10 patients, one has discontinued home parenteral nutrition (HPN), seven patients remain well, one patient has recently moved to the USA, and one patient has died after major abdominal surgery. All children had either normal or an accelerated rate of growth on HPN and developmentally all have progressed well. All the children over 5 years attend normal schools. The major complication of treatment was line sepsis with an overall rate of one episode in 476 days and a total of nine central lines (five patients) have required replacement giving an average line life of 680 days. For those children unfortunate enough to suffer from severe intestinal failure, HPN is preferable to prolonged hospital treatment and offers the chance of a good quality of life with prolonged survival. 相似文献
43.
44.
45.
46.
The fat embolism syndrome 总被引:3,自引:0,他引:3
47.
Orbital irradiation for Graves' ophthalmopathy: Is it safe? A long-term follow-up study 总被引:4,自引:0,他引:4
Wakelkamp IM Tan H Saeed P Schlingemann RO Verbraak FD Blank LE Prummel MF Wiersinga WM 《Ophthalmology》2004,111(8):1557-1562
PURPOSE: We evaluated the frequency of long-term complications of orbital irradiation (radiation-induced tumors, cataract, and retinopathy) in comparison with glucocorticoids. DESIGN: We conducted a follow-up study in a cohort of 245 Graves' ophthalmopathy patients who had been treated with retrobulbar irradiation (20 Gy in 2 weeks) and/or oral glucocorticoids between 1982 and 1993 in our institution. Irradiated patients were compared with nonirradiated patients. METHODS: Data on mortality and cause of death were obtained. Living patients were invited to participate in a follow-up study. Possible retinopathy was assessed in a masked fashion and defined as the presence of > or =1 hemorrhages and/or microaneurysms on red-free retina photographs. If >5 lesions were present, patients were categorized as suffering from definite retinopathy. Cataract was assessed using the Lens Opacity Classification System II score. MAIN OUTCOME MEASURES: Mortality, prevalence of retinopathy, prevalence of cataract, and type of cataract. RESULTS: Thirty-seven of the 245 patients had died, none of them from an intracranial tumor. Mortality was similar in the irradiated (27/159 [17%]) and nonirradiated patients (10/86 [12%]; P = 0.264). One hundred fifty-seven of the 208 living patients (75%) consented to participate in a follow-up ophthalmologic investigation; the mean follow-up time (+/- standard deviation) was 11+/-3 years. Possible retinopathy was present in 15% of patients, 22 of the irradiated and 1 of the nonirradiated patients (P = 0.002). In 5 patients (all had been irradiated), definite retinopathy (i.e., >5 retinal lesions) was present. Of these, 3 had diabetes mellitus, and 1 had hypertension. Diabetes was associated with both possible (P = 0.029) and definite (P = 0.005) retinopathy, with a relative risk of 21 (95% confidence interval, 3-179). The prevalence and severity of cataract were similar in the radiotherapy group (29%) and the glucocorticoid group (34%); it should be noted that 88 of 104 of the irradiated patients were also treated with oral glucocorticoids. CONCLUSION: The data suggest that orbital irradiation for Graves' ophthalmopathy is a safe treatment modality, except possibly for diabetic patients. 相似文献
48.
Zandieh-Doulabi B Dop E Schneiders M Schiphorst MP Mansen A Vennström B Dijkstra CD Bakker O Wiersinga WM 《The Journal of endocrinology》2003,179(3):379-385
Many metabolic processes occur simultaneously in the liver in different locations along the porto-central axis of the liver units. These processes are often regulated by hormones, one of which is thyroid hormone which for its action depends on the presence of the different isoforms of the thyroid hormone receptor (TR). These are encoded by two genes: c-erbA-alpha encoding TRalpha1 and TRalpha2 and their respective Delta isoforms, and c-erbA-beta which encodes TRbeta1, TRbeta2 and TRbeta3. We recently found a zonal (pericentral) expression of and a diurnal variation in the TRbeta1 isoform in rat liver. We were therefore also interested to see whether TRalpha1 and TRalpha2 expression showed similar characteristics. For this reason we raised both polyclonal and monoclonal antibodies against TRalpha1 and TRalpha2 isoforms and characterised these. Antibody specificity was tested using Western blots and immunohistochemistry in liver of TR isoform-specific knockout animals. Using these antibodies we found that the TRalpha1 and TRalpha2 isoforms are zonally expressed around the central vein in rat liver. The experiments show that the portal to central gradient of TRalpha1 is broader than that of TRbeta1. Moreover, the expression of the TRalpha2 protein showed a diurnal variation with a peak in the afternoon when the animals are least active whereas no such variation was found for the TRalpha1 protein.From our data it appears that both the TRalpha1 and TRalpha2 isoforms show a zonal distribution in liver. This finding, together with the observed diurnal rhythm, has major implications for interpreting and timing experiments concerning the TR and its downstream actions in liver. 相似文献
49.
Prummel MF Bakker A Wiersinga WM Baldeschi L Mourits MP Kendall-Taylor P Perros P Neoh C Dickinson AJ Lazarus JH Lane CM Heufelder AE Kahaly GJ Pitz S Orgiazzi J Hullo A Pinchera A Marcocci C Sartini MS Rocchi R Nardi M Krassas GE Halkias A 《European journal of endocrinology / European Federation of Endocrine Societies》2003,148(5):491-495
To improve management of patients with Graves' orbitopathy, a multi-center collaborative approach is necessary in order to have large enough sample sizes for meaningful randomized clinical trials. This is hampered by a lack of consensus on how to investigate the eye condition. The European Group on Graves' Orbitopathy aims to overcome this and has designed a preliminary case record form (CRF) to assess Graves' orbitopathy patients. This form was used in this first multi-center study. AIM: To investigate patient characteristics and treatment strategies in 152 new consecutively referred patients with thyroid eye disease seen in nine large European referral centers. METHODS: Newly referred patients with Graves' orbitopathy were included who were seen between September and December 2000. Demographic data and a complete ophthalmological assessment were recorded. RESULTS: One-hundred and fifty-two patients (77% females) were included. Diabetes was present in 9%, and glaucoma or cataract in 14% of patients. Forty percent were current smokers, 9% also had dermopathy, and only 33% reported a positive family history of thyroid disease. Mild eye disease was seen in 40%, moderately severe eye disease was seen in 33% and severe eye disease was seen in 28% of patients. Soft tissue involvement was the most frequent abnormality (seen in 75%), proptosis > or =21 mm was found in 63%, eye motility dysfunction in 49%, keratopathy in 16% and optic nerve involvement was found in 21% of patients. According to the clinical impression, 60% had active eye disease. Immunosuppressive treatment was planned more frequently in active patients (57/86; 66%) than in inactive patients (5/57, 9%; Chi-square 46.16; P<0.02). There were no important differences among the eight centers regarding the severity and the activity of their patients. CONCLUSIONS: In view of the large number of patients recruited in only 4 months, multi-center studies in the eight EUGOGO centers appear to be feasible. 相似文献
50.
Zandieh Doulabi B Platvoet-ter Schiphorst M van Beeren HC Labruyere WT Lamers WH Fliers E Bakker O Wiersinga WM 《Endocrinology》2002,143(3):979-984
We investigated the distribution and diurnal variation of TR(beta)1 protein expression in liver with specific antibodies against TR(beta)1. Immunohistochemistry showed a zonal distribution of TR(beta)1 with maximum expression in the pericentral zone matching some known T(3)-responsive enzyme activities in the liver, such as glutamine synthetase, cholesterol 7alpha- hydroxylase, and spot 14. Combining immunohistochemistry and image analysis we found and quantified the same zonal distribution for 5'-deiodinase type 1 as for TR(beta)1. Western blot analysis revealed a profound diurnal variation for TR(beta)1 protein expression, with highest levels at the beginning of the dark period. TR(beta)1 diurnal variation partly overlaps with the T(3)-responsive genes, cholesterol 7alpha-hydroxylase and spot 14. Furthermore, TR(beta)1 distribution along the porto-central axis does not change during the day, indicating that the zonal expression of TR(beta)1 is stable. This is the first time that zonal distribution in liver has been demonstrated for a member of the nuclear receptor family. This finding together with the observed diurnal rhythm has major implications for interpreting and timing experiments concerning the TR and its downstream actions in liver. 相似文献